Evonik Vland Biotech JV commences operations
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
The investment will catalyse various components of the IndiaAI Mission
Connecting new production and consumption areas of chilled food by low-carbon transportation services
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Distributes Ayushman cards to several beneficiaries
Subscribe To Our Newsletter & Stay Updated